Researchers sought to determine whether adding eltrombopag to standard immunosuppression therapy would be effective for patients with severe aplastic anemia.
Researchers sought to determine whether adding eltrombopag to standard immunosuppressive therapy would improve outcomes in children with SAA.
Researchers sought to determine whether treatment with eltrombopag and immunosuppression would reduce risk of relapse for patients with severe aplastic anemia.
Researchers sought to find possible relationships between mutations in human leukocyte antigen alleles and clinical features associated with aplastic anemia.
Improvement seen in the rate, rapidity, strength of hematologic response in previously untreated patients with severe aplastic anemia
Researchers sought to better understand germline predisposition to aplastic anemia and how it contributes to proper diagnosis of the disease.
Researchers sought to determine whether patients with anemia had an increased risk of ischemic stroke and poststroke mortality.
Researchers sought to determine whether blood counts would be good predictors of response to immunosuppressive therapy plus eltrombopag for patients with severe aplastic anemia.
Researchers sought to determine whether paroxysmal nocturnal hemoglobinuria clones might predict treatment responses for patients with MDS and aplastic anemia.
Febrile neutropenia commonly causes morbidity and mortality in children with severe aplastic anemia but little is known about the spectrum of infections.
